These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 24118095)

  • 1. Adverse drug reactions during ceftriaxone treatment can cause severe hemolysis.
    Liu W; Yu D
    Pediatr Allergy Immunol; 2014 Feb; 25(1):101-2. PubMed ID: 24118095
    [No Abstract]   [Full Text] [Related]  

  • 2. Severe ceftriaxone-induced hemolysis complicated by diffuse cerebral ischemia in a child with sickle cell disease.
    Schuettpelz LG; Behrens D; Goldsmith MI; Druley TE
    J Pediatr Hematol Oncol; 2009 Nov; 31(11):870-2. PubMed ID: 19829151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatal ceftriaxone-induced hemolysis in a child with acquired immunodeficiency syndrome.
    Borgna-Pignatti C; Bezzi TM; Reverberi R
    Pediatr Infect Dis J; 1995 Dec; 14(12):1116-7. PubMed ID: 8745031
    [No Abstract]   [Full Text] [Related]  

  • 4. Intravascular haemolysis in a patient on ceftriaxone with demonstration of anticeftriaxone antibodies.
    Dinesh D; Dugan N; Carter J
    Intern Med J; 2008 Jun; 38(6):438-41. PubMed ID: 18613898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemolytic anemia from ceftriaxone in an elderly patient: a case report.
    Imam SN; Wright K; Bhoopalam N; Choudhury A
    J Am Med Dir Assoc; 2008 Oct; 9(8):610-1. PubMed ID: 19083297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ceftriaxone-related fatal hemolysis in an adolescent with perinatally acquired human immunodeficiency virus infection.
    Moallem HJ; Garratty G; Wakeham M; Dial S; Oligario A; Gondi A; Rao SP; Fikrig S
    J Pediatr; 1998 Aug; 133(2):279-81. PubMed ID: 9709722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ceftriaxone-induced hemolysis in a child with Lyme arthritis: a case for antimicrobial stewardship.
    Boggs SR; Cunnion KM; Raafat RH
    Pediatrics; 2011 Nov; 128(5):e1289-92. PubMed ID: 21969285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe hemolysis induced by ceftriaxone in a child with sickle-cell anemia.
    Viner Y; Hashkes PJ; Yakubova R; Segal-Kupershmit D; Luder AS
    Pediatr Infect Dis J; 2000 Jan; 19(1):83-5. PubMed ID: 10643859
    [No Abstract]   [Full Text] [Related]  

  • 9. Ceftriaxone associated hemolysis.
    Maraspin V; Lotric-Furlan S; Strle F
    Wien Klin Wochenschr; 1999 May; 111(9):368-70. PubMed ID: 10407998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ceftriaxone-related hemolysis and acute renal failure.
    Demirkaya E; Atay AA; Musabak U; Sengul A; Gok F
    Pediatr Nephrol; 2006 May; 21(5):733-6. PubMed ID: 16491410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ceftriaxone causes drug-induced immune thrombocytopenia and hemolytic anemia: characterization of targets on platelets and red blood cells.
    Grossjohann B; Eichler P; Greinacher A; Santoso S; Kroll H
    Transfusion; 2004 Jul; 44(7):1033-40. PubMed ID: 15225244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ceftriaxone-induced hemolytic anemia in a child successfully managed with intravenous immunoglobulin.
    Vehapoğlu A; Göknar N; Tuna R; Çakır FB
    Turk J Pediatr; 2016; 58(2):216-219. PubMed ID: 27976566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Albuterol-induced myocardial ischemia in sickle cell anemia after hemolysis from ceftriaxone administration.
    Corso M; Ravindranath TM
    Pediatr Emerg Care; 2005 Feb; 21(2):99-101. PubMed ID: 15699818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ceftriaxone-induced hemolytic anemia: case report and review of literature.
    Northrop MS; Agarwal HS
    J Pediatr Hematol Oncol; 2015 Jan; 37(1):e63-6. PubMed ID: 24878619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe hemolytic crisis after ceftriaxone administration.
    Goyal M; Donoghue A; Schwab S; Hasbrouck N; Khojasteh S; Osterhoudt K
    Pediatr Emerg Care; 2011 Apr; 27(4):322-3. PubMed ID: 21467885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serologic characteristics of ceftriaxone antibodies in 25 patients with drug-induced immune hemolytic anemia.
    Arndt PA; Leger RM; Garratty G
    Transfusion; 2012 Mar; 52(3):602-12. PubMed ID: 21880048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ceftriaxone induced hemolysis complicated by acute renal failure.
    Kapur G; Valentini RP; Mattoo TK; Warrier I; Imam AA
    Pediatr Blood Cancer; 2008 Jan; 50(1):139-42. PubMed ID: 16602117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatal hemolysis caused by ceftriaxone.
    Lascari AD; Amyot K
    J Pediatr; 1995 May; 126(5 Pt 1):816-7. PubMed ID: 7752013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-induced hemolysis.
    Dausset J; Contu L
    Annu Rev Med; 1967; 18():55-70. PubMed ID: 5337612
    [No Abstract]   [Full Text] [Related]  

  • 20. Ceftriaxone-induced hemolytic anemia and hepatitis in an adolescent with hemoglobin SC disease.
    Bell MJ; Stockwell DC; Luban NL; Shirey RS; Shaak L; Ness PM; Wong EC
    Pediatr Crit Care Med; 2005 May; 6(3):363-6. PubMed ID: 15857541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.